ServicenavigationHauptnavigationTrailKarteikarten


Forschungsstelle
INNOSUISSE
Projektnummer
103.243.1 IP-LS
Projekttitel
Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype
Projekttitel Englisch
Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Texte zu diesem Projekt

 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
Anzeigen

Erfasste Texte


KategorieText
Kurzbeschreibung
(Deutsch)
Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype
Kurzbeschreibung
(Englisch)
Developing the first effective targeted therapy for NRAS melanoma
Abstract
(Deutsch)
Melanoma is the fifth most common cancer in Switzerland and the most lethal skin cancer. NRAS-mutated melanoma is the most aggressive subtype, with no effective therapy after immunotherapy failure. We will develop the first effective targeted therapy combination against this often fatal disease.
Abstract
(Englisch)
Melanoma is the fifth most common cancer in Switzerland and the most lethal skin cancer. NRAS-mutated melanoma is the most aggressive subtype, with no effective therapy after immunotherapy failure. We will develop the first effective targeted therapy combination against this often fatal disease.